Additional information - d10, g4, g7, h2, h3, h4, h6, h10 with respect to the returned unit it has passed all specific functional testing requirements.When unit is properly positioned and put under pressure unit would not have slipped.Preventative maintenance and cleaning required at this time.A device history record was reviewed with no abnormalities related to the reported failure.The device passed all required inspection points with no associated mrr's, variances or rework.The reported complaint was not confirmed.The definite root cause of the reported condition could not be reliably determined.Most probable root causes outlined in the risk management file: incorrectly assembled device, improper technique used during procedure, inadequately maintained device used for procedure, off-label use of device during procedure (user error).Device identifier # (b)(4).Between 05nov2019 and 30jun2020, approximately 2,200 mdrs submitted electronically by integra lifesciences via trackwise, integra's complaint handling system, were not received by cdrh due to a computer system issue.Within this time period, an error with integra's middleware, which facilitates communications between trackwise and the fda system, caused the complaint records to close and indicate we had received an acknowledgement 3 from the fda when we had not.Integra interpreted the acknowledgement as a successful submission; however, subsequent investigation revealed the acknowledgement 3 received was from our middleware and not from the fda (these acknowledgements have been retained as part of the documentation of the mdr).The malfunction was related to the relocation of the trackwise application to a new data center during the transition of integra's corporate headquarters from plainsboro, nj to princeton, nj.Previously, integra had been successfully receiving acknowledgements 1, 2, and 3 from the fda, and our records reflect these acknowledgements, including the date and time stamps.Capa pr 229048 and nc 20-011 have been opened by integra to further investigate the nonconformance and develop a corrective action plan.The middleware error has been corrected, and integra has filed mdrs since the correction and verified that the appropriate acknowledgements have been received from the fda.Integra is resubmitting all impacted mdr reports for the time period 05nov2019 through 30jun2020.Integra lifesciences contacted (b)(4) office of product evaluation and quality on july 8-9, 2020 to report these issues regarding mdr reports.
|